OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...

Researchers discovered a compound in python blood, para-tyramine-O-sulfate (pTOS), that suppresses appetite and promotes weight loss in mice. Unlike current GLP-1 drugs such as semaglutide, it avoids ...

Researchers have found a metabolite in Burmese pythons that suppresses appetite in mice without some of GLP-1's side effects. And humans make it, too.

OpenAI on Thursday announced the acquisition of Astral, the developer of open source Python tools that include uv, Ruff and ty. It says that it plans to integrate them with Codex, its AI coding agent ...

Scientists have discovered a novel metabolite in pythons that quells appetite without causing gastrointestinal side effects ...

From idea to live app in minutes: a straightforward, five-step way to start building with AI—no coding experience needed.

Dhaka, March 20 -- OpenAI announced on Thursday that it is acquiring Astral, a prominent Python toolmaker, as part of its strategy to expand its AI coding offerings and compete more effectively with ...

In a move clearly designed to strengthen its position among developers, OpenAI has acquired Python tool maker Astral. The house of Altman expects the deal to strengthen the ecosystem for its Codex ...

PYTHON blood could hold the key to the next blockbuster weight loss treatment, scientists say. The reptiles can go months without eating after consuming a massive meal, while still remaining ...

China's intense contest ecosystem meets India's grassroots coding grind in a record-setting global competition.